Russell Investments Trims Elevance Health Stake

Investment firm sells 25,511 shares of health insurance giant

Published on Mar. 9, 2026

Got story updates? Submit your updates here. ›

Russell Investments Group Ltd. has reduced its position in Elevance Health, Inc. (NYSE: ELV) by 4.5%, selling 25,511 shares of the health insurance company's stock during the third quarter. Russell Investments now owns approximately 542,692 shares, or 0.24% of Elevance Health's outstanding stock, valued at $175.2 million as of the most recent SEC filing.

Why it matters

Elevance Health is one of the largest health insurance providers in the United States, and changes in institutional ownership can signal shifts in market sentiment around the company's performance and outlook. Russell Investments' decision to trim its Elevance Health position may indicate broader concerns about the stock's valuation or growth prospects.

The details

According to the SEC filing, Russell Investments sold 25,511 shares of Elevance Health during the third quarter, reducing its total position to 542,692 shares. The investment firm now owns approximately 0.24% of Elevance Health's outstanding stock, which was valued at $175.2 million as of the filing date. The sale comes as Elevance Health's stock price has fluctuated in recent months, with the company facing headwinds such as rising medical costs and regulatory uncertainty.

  • Russell Investments sold the 25,511 shares during the third quarter of the year.
  • The SEC filing disclosing the transaction was made on March 9, 2026.

The players

Russell Investments Group Ltd.

A global asset management firm that provides investment solutions to institutional and individual investors.

Elevance Health, Inc.

A large U.S.-based health benefits company that provides a broad range of health insurance products and related services.

Got photos? Submit your photos here. ›

The takeaway

The reduction in Russell Investments' Elevance Health position suggests potential concerns about the company's outlook, though the overall impact on Elevance Health's stock price and performance remains to be seen. Investors will likely continue to monitor institutional ownership changes and other market signals to gauge the health of the health insurance industry and Elevance Health's competitive position.